Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07739901) titled 'Korean Real-world Study on MASLD/MASH Outcomes' on July 28.

Study Type: Observational

Primary Sponsor: Novo Nordisk A/S

Condition: MASLD/MASH

Intervention: Other: No treatment is given

Recruitment Status: Not recruiting

Date of First Enrollment: July 13, 2026

Target Sample Size: 10000

Countries of Recruitment: South Korea

To know more, visit https://clinicaltrials.gov/study/NCT07739901

Disclaimer: Curated by HT Syndication....